Long-term diosbulbin B treatment induced liver fibrosis in mice
- 25 October 2018
- journal article
- research article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 298, 15-23
- https://doi.org/10.1016/j.cbi.2018.10.015
Abstract
No abstract availableKeywords
Funding Information
- State Major Science and Technology Special Projects (2015ZX09501004-002-002)
This publication has 33 references indexed in Scilit:
- Epithelial-mesenchymal transitions: insights from developmentDevelopment, 2012
- Antitumor activity of Dioscorea bulbifera L. rhizome in vivoFitoterapia, 2012
- The basics of epithelial-mesenchymal transitionJCI Insight, 2009
- Hepatic fibrosisCurrent Opinion in Gastroenterology, 2009
- Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected casesEuropean Journal of Gastroenterology & Hepatology, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Toll-like receptors: From the discovery of NFκB to new insights into transcriptional regulations in innate immunityBiochemical Pharmacology, 2006
- Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF‐β as major players and therapeutic targetsJournal of Cellular and Molecular Medicine, 2006
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994